Quality of Anticoagulation and Treatment Satisfaction in Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonist: Result from the KORean Atrial Fibrillation Investigation II

BACKGROUND: Vitamin K antagonist (VKA) to prevent thromboembolism in non-valvular atrial fibrillation (NVAF) patients has limitations such as drug interaction. This study investigated the clinical characteristics of Korean patients treated with VKA for stroke prevention and assessed quality of VKA t...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Seil, Kim, June-Soo, Oh, Yong-Seog, Shin, Dong-Gu, Pak, Hui-Nam, Hwang, Gyo-Seung, Choi, Kee-Joon, Kim, Jin-Bae, Lee, Man-Young, Park, Hyung-Wook, Kim, Dae-Kyeong, Jin, Eun-Sun, Park, Jaeseok, Oh, Il-Young, Shin, Dae-Hee, Park, Hyoung-Seob, Kim, Jun Hyung, Kim, Nam-Ho, Ahn, Min-Soo, Seo, Bo-Jeong, Kim, Young-Joo, Kang, Seongsik, Lee, Juneyoung, Kim, Young-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262187/
https://www.ncbi.nlm.nih.gov/pubmed/30505257
http://dx.doi.org/10.3346/jkms.2018.33.e323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262187/
https://www.ncbi.nlm.nih.gov/pubmed/30505257
http://dx.doi.org/10.3346/jkms.2018.33.e323

Ejemplares similares